Novavax Inc. Stock Falls Thursday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. (NVAX) shed 3.17% to $20.79 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.35% to 11,144.96 and Dow Jones Industrial Average falling 0.02% to 33,546.32. This was the stock's second consecutive day of losses. Novavax Inc. closed $215.71 short of its 52-week high ($236.50), which the company reached on December 20th.
The stock underperformed when compared to some of its competitors Thursday, as Replimune Group Inc. (REPL) rose 1.40% to $19.49, VBI Vaccines Inc. (VBIV) fell 2.18% to $0.62, and AnaptysBio Inc. (ANAB) fell 0.70% to $28.17. Trading volume (2.7 M) remained 2.5 million below its 50-day average volume of 5.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 17, 2022.
(END) Dow Jones Newswires
November 17, 2022 17:13 ET (22:13 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.